<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04848363</url>
  </required_header>
  <id_info>
    <org_study_id>BEK25011994</org_study_id>
    <nct_id>NCT04848363</nct_id>
  </id_info>
  <brief_title>Analgesic Effect of Quadratus Lumborum Block in Laparoscopic Hemicolectomy</brief_title>
  <official_title>Analgesic Effect of Quadratus Lumborum Block in Laparoscopic Hemicolectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Petrovsky National Research Centre of Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Petrovsky National Research Centre of Surgery</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of the effectiveness: Quadratus lumborum (QL) block by levobupivacaine with&#xD;
      placebo.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients will receive standard anaesthesia using fentanyl, protocol, cisatracurium and&#xD;
      sevoflurane. Prevention of nausea and vomiting is performing using Apfel score.&#xD;
&#xD;
      All patients will receive post operative multimodal analgesia using paracetamol, ketoprofen,&#xD;
      tramadol, and trimeperidine if numerical rating scale &gt; 3 The study assumes use of QL block&#xD;
      by levobupivacaine.in comparison with placebo in order to demonstrate the effectiveness of QL&#xD;
      block during the operation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 16, 2021</start_date>
  <completion_date type="Anticipated">May 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Distribution: randomized Intervention model: parallel distribution 2 groups&#xD;
Control group: patients receiving general anesthesia with propofol, fentanyl and cisatracurium for induction and sevoflurane, fentanyl and cisatracurium for maintaining anesthesia. Patients receiving postoperative multimodal intravenous analgesia with paracetamol, ketoprofen, tramadol, and trimeperidine. Before surgery will be performde bilateral blockade of the QL muscle with normal saline.&#xD;
Study group: patients receiving general anesthesia with propofol, fentanyl and cisatracurium for induction and sevoflurane, fentanyl and cisatracurium for maintaining anesthesia. Patients receiving postoperative multimodal intravenous analgesia with paracetamol, ketoprofen, tramadol, and trimeperidine. The QL blockade will be performed under ultrasound guidance using 20 ml of a solution of levobupivacaine 2.5 mg / ml.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Triple blindness. The Principal Investigator performing the blockade knows the randomization group. The anesthesiologist, postoperative pain assessor, and study participant do not know the randomization group.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>NRS (Numeric rating scale)</measure>
    <time_frame>two hours after surgery</time_frame>
    <description>NRS scale 0-10, &quot;no pain&quot;; 10, &quot;worst pain imaginable&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The need for opioid analgesics during surgery</measure>
    <time_frame>on operations</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The need for opioid analgesics for postoperative pain relief</measure>
    <time_frame>72 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The need for antiemetic drugs to relieve postoperative nausea and vomiting</measure>
    <time_frame>12 hours after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of prolonged post-operative ileus</measure>
    <time_frame>first two weeks after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood glucose level</measure>
    <time_frame>after induction into anesthesia, immediately after the end of the surgery, 12 hours after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of blood lactate</measure>
    <time_frame>after induction into anesthesia, immediately after the end of the surgery, 12 hours after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of cortisol in the blood</measure>
    <time_frame>after induction into anesthesia and immediately after the end of the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of prolactin in the blood</measure>
    <time_frame>after induction into anesthesia and immediately after the end of the surgery.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Post Operative Pain</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients receiving general anesthesia with propofol, fentanyl and cisatracurium for induction and sevoflurane, fentanyl and cisatracurium for maintaining anesthesia. Patients receiving postoperative multimodal intravenous analgesia with paracetamol, ketoprofen, tramadol, and trimeperidine. In this group, after induction of anesthesia before the operation, bilateral blockade of the square dorsi muscle is performed under ultrasound guidance using 20 ml of a solution of levobupivacaine 2.5 mg / ml.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients receiving general anesthesia with propofol, fentanyl and cisatracurium for induction and sevoflurane, fentanyl and cisatracurium for maintaining anesthesia. Patients receiving postoperative multimodal intravenous analgesia with paracetamol, ketoprofen, tramadol, and trimeperidine. In this group, after induction of anesthesia before surgery, bilateral blockade of the square dorsi muscle is performed under ultrasound guidance using 20 ml of saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Quadratus lumborum block</intervention_name>
    <description>QL block will be used for perioperative anesthesia. The blockade will be performed bilaterally by levobupivacaine (20ml) at concentration 0.25%.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who have undergone left-sided or right-sided laparoscopic hemicolectomy.&#xD;
&#xD;
          -  Patient's willingness and ability to sign an informed consent document&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy to local anesthetics&#xD;
&#xD;
          -  Chronic pain syndrome and associated opioid use.&#xD;
&#xD;
          -  Coagulopathy&#xD;
&#xD;
          -  Uncontrolled diabetes mellitus&#xD;
&#xD;
          -  Physical Status Classification System scale above 3&#xD;
&#xD;
          -  Diseases associated with the pathology of the hypothalamus&#xD;
&#xD;
          -  Diseases associated with the pathology of the pituitary gland&#xD;
&#xD;
          -  Diseases associated with the pathology of the adrenal glands&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Evgenii Bespalov</last_name>
    <phone>+79854633843</phone>
    <email>evgenbespalovv@yandex.ru</email>
  </overall_contact>
  <location>
    <facility>
      <name>Petrovsky Research National Centre of Surgery ( Petrovsky NRCS)</name>
      <address>
        <city>Moscow</city>
        <zip>119991</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evgenii Bespalov</last_name>
      <phone>+79854633843</phone>
      <email>evgenbespalovv@yandex.ru</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>March 12, 2021</study_first_submitted>
  <study_first_submitted_qc>April 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2021</study_first_posted>
  <last_update_submitted>June 16, 2021</last_update_submitted>
  <last_update_submitted_qc>June 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Petrovsky National Research Centre of Surgery</investigator_affiliation>
    <investigator_full_name>Evgenii Bespalov,MD</investigator_full_name>
    <investigator_title>Doctor of the department of anesthesiology and resuscitation</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>All patient data will be confidential</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

